Serological and molecular evidence of rhesus papillomavirus type 1 infections in tissues from geographically distinct institutions

References

1. Barber S., Werdel J., Symbula M., Williams J., Burkett B., Taylor P., Roche J., Crum C. 1992; Seroactivity to HPV-16 proteins in women with early cervical neoplasia. Cancer Immunology and Immunotherapy 35:33–38
   [Google Scholar]
2. Firzlaff J., Hsia C., Halbert C., Jenison S., Galloway D. 1987; Polyclonal antibodies to human papillomavirus type 6b and type 16 bacterially derived fusion proteins. Cancer Cells 5:105–113
   [Google Scholar]
3. Gage J., Meyers C., Wettstein F. 1990; The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties. Journal of Virology 64:723–730
   [Google Scholar]
4. Galloway D. 1994; Papillomavirus capsids: a new approach to identify serological markers of HPV infection. Journal of the National Cancer Institute 86:474–475
   [Google Scholar]
5. Galloway D., Jenison S. 1990; Characterization of the humoral immune response to genital papillomaviruses. Molecular Biological Medicine 7:59–72
   [Google Scholar]
6. Ghosh A., Smith N., Stacey S., Glew S., Connor M., Arrand J., Stern P. 1993; Serological responses to HPV 16 in cervical dysplasia and neoplasia - correlation of antibodies to E6 with cervical cancer. International Journal of Cancer 53:591–596
   [Google Scholar]
7. Guido M. C., Zamorano R., Garrido-Guerrero E., Gariglio P., García-Carrancá A. 1992; Early promoters of genital and cutaneous human papillomaviruses are differentially regulated by the bovine papillomavirus type 1 E2 gene product. Journal of General Virology 73:1395–1400
   [Google Scholar]
8. Jenison S., Firzlaff J., Langenberg A., Galloway D. 1988; Identification of immunoreactive antigens of human papillomavirus type 6b by using Escherichia coff-expressed fusion proteins. Journal of Virology 62:2115–2123
   [Google Scholar]
9. Jenison S., Yu X., Valentine J., Koutsky L., Christiansen A., Beckmann A., Galloway D. 1990; Evidence of prevalent genital-type human papillomavirus infections in adults and children. Journal of Infectious Disease 162:60–69
   [Google Scholar]
10. Jenison S., Yu X., Valentine J., Galloway D. 1991; Characterization of human antibody-reactive epitopes encoded by human papillomavirus type-16 and type-18. Journal of Virology 65:1208–1218
    [Google Scholar]
11. Jochmus I., Bavinck J., Gissmann L. 1992; Detection of antibodies to the E4 or E7 proteins of human papillomaviruses (HPV) in human sera by western blot analysis - type-specific reaction of anti-HPV 16 antibodies. Molecular and Cellular Probes 6:319–325
    [Google Scholar]
12. Jochmus-Kudielka I., Bavinck J., Claas F., Schneider A., van der Woulde F., Gissmann L. 1992; Seroreactivity against HPV-16-E4 and E7-proteins in renal transplant recipients and pregnant women. Journal of Investigative Dermatology 98:389–390
    [Google Scholar]
13. Kirnbauer R., Booy F., Cheng N., Lowry D., Schiller J. 1992; Papillomavirus LI major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proceedings of the National Academy of Sciences, USA 89:12180–12184
    [Google Scholar]
14. Kloster B., Manias D., Ostrow R., Shaver M., McPherson S., Rangen S., Uno H., Faras A. 1988; Molecular cloning and characterization of the DNA of two papillomaviruses from monkeys. Virology 166:30–40
    [Google Scholar]
15. Kochel H., Sievert K., Monazahian M., Mittelstadt-Deterding A., Teichmann A., Thomssen R. 1991; Antibodies to human papillomavirus type-16 in human sera as revealed by the use of prokaryotically expressed viral gene products. Virology 182:644–654
    [Google Scholar]
16. Onda T., Kanda T., Zanma S., Yasugi T., Watanabe S., Kawana T., Ueda D., Yoshidawa H., Taketani Y., Yoshiike K. 1993; Association of the antibodies against human papillomavirus-16 E4 and E7 proteins with cervical cancer positive for human papillomavirus DNA. International Journal of Cancer 54:624–628
    [Google Scholar]
17. Ostrow R., McGlennen R., Shaver M., Kloster B., Houser D., Faras A. 1990; A rhesus monkey model for sexual transmission of a papillomavirus isolated from a squamous cell carcinoma. Proceedings of the National Academv of Sciences, USA 87:8170–8174
    [Google Scholar]
18. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual 2nd edn New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
19. Schneider A., Klrchhoff T., Meinhardt G., Gissmann L. 1992; Repeated evaluation of human papillomavirus 16 status in cervical swabs of young women with a history of normal Papanicolaou smears. Obstetrics & Gynecology 79:683–688
    [Google Scholar]
20. Suchankova A., Ritterova L., Krcmar M., Krchnak V., Vagner J., Jochmus L., Glissmann L., Kanka J., Vonka V. 1991; Comparison of ELISA and Western blotting for human papillomavirus type 16 E7 antibody determination. Journal of General Virology 72:2577–2581
    [Google Scholar]
21. Suchánková A., Ritterová M., Krchnak V., Kamsikova E., Kanka J., Vagner J., Vonka V. 1992; Range of HPV-16 E7 antibodies in cervical cancer patients and healthy subjects. International Journal of Cancer 51:837–838
    [Google Scholar]
22. Wikstrom A., Eklund C., Vonkrogh G., Lidbrink P., Dillner J. 1992; Levels of immunoglobulin-G antibodies against defined epitopes of the LI and L2 capsid proteins of human papillomavirus type-6 are elevated in men with a history of condylomata acuminata. Journal of Clinical Microbiology 30:1795–1800
    [Google Scholar]